Keywords: Liver, Cancer, MRI, Steatohepatitis-associated Hepatocellular Carcinoma, cow colustrum, therapyNutraceuticals is an emerging industry with the potential to cater the needs of many therapeutic domains, including cancer a major cause of health concerns. Despite the currently available therapeutics, complication and effective medical management of HCC, particularly at an advanced stage has several limitations. Hence, in the present study an alternative approach using an animal product cow colostrum as therapeutics for HCC is explored in STAM-induced non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice. If successful this might prove to be a very viable and effective management for NASH-associated HCC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords